Over the next few years, the market for surgical dressings is expected to grow at a CAGR of 5.2%.
COVID-19 had an impact on the surgical dressing market due to the cancellation of elective procedures worldwide, including diagnostics and wound care treatment.Due to the regulatory authorities' strict guidance to prevent any non-emergent surgeries, the volume of surgeries drastically decreased throughout the pandemic. For instance, as per a research article published in the Brazilian Journal of Gynecology and Obstetrics, in July 2020, both the National Health Agency and the National Health Surveillance Agency advised the postponement of elective and non-essential surgeries. This had a considerable impact on the number of surgical procedures, which decreased by 33.4% in the country. However, resumed surgical procedures and wound treatment services have increased demand for the surgical dressing market. For instance, as per an article published in December 2021, a total of 13,108,567 surgical procedures were identified from January 1, 2019, through January 30, 2021, based on 3498 Current Procedural Terminology (CPT) codes. Thus, with the increased number of surgical procedures, the studied market is growing and is expected to reach its full potential in the next two to three years.
Market growth is being helped by things like the rise in lifestyle diseases and the number of surgeries around the world, as well as the rise in the number of ambulatory surgical centers and organ transplants.
The increasing incidences of chronic wounds, ulcers, diabetic ulcers, and burns are the key factor driving the demand for surgical dressings over the forecast period. For instance, according to data published by the NPIAP in August 2021, around 2.5 million people are reported every year with pressure ulcers in the United States. Also, per the report published by the American Burn Association in February 2021, more than 400,000 people receive burn injury treatment every year in the United States.
Additionally, the growing burden of chronic diseases is driving the demand for effective and advanced treatment services involving surgical procedures, which are anticipated to fuel the demand for surgical dressing during surgery, hence propelling the market's growth. For instance, according to the data published by the OECD, in August 2022, about 94.87 thousand surgeries were performed in Portugal, followed by 49.33 thousand in Denmark, 32.84 thousand in Ireland, and 21.5 thousand in Norway in 2021.
Also, the number of knee and hip replacement surgeries has increased globally, and persistent wound drainage is a well-known complication following these procedures, which commonly leads to wound development. This is also expected to increase the demand for surgical dressings, hence bolstering the market's growth. For instance, as per the American Joint Registry 2021 report, more than 2.4 million hip and knee surgeries were reported in the United States in 2021, with an increase of 18.3% in total procedural volume compared to 2020.
Furthermore, the increasing focus of companies on developing effective surgical dressings is also contributing to the growth of the market. For instance, in June 2022, Medline released its Optifoam Gentle EX Foam Dressing. When combined with a pressure injury prevention protocol, the product is intended to help displace pressure. The product has five distinct layers that absorb shear stress, friction, and moisture. Also, in May 2022, the Technical University of Munich (TUM) in Germany developed a new kind of film dressing using mucin molecules that can not only protect wounds like conventional dressings but also add active drugs to accelerate wound healing, expel bacteria, inhibit inflammation, and finally decompose on the skin by itself, which is a new revelation for sensitive skin.
Therefore, owing to the aforementioned factors, the studied market is expected to grow over the forecast period. However, the stringent regulatory policies, lack of reimbursement, and high treatment costs are likely to hinder the growth of the surgical dressing market over the forecast period.
In addition, diabetes is expected to be a major factor causing wounds. Thus, a rise in the number of people suffering from diabetes is anticipated to drive the market. For instance, as per the 2022 statistics published by the IDF, more than 51 million people in the NAC Region and 537 million people worldwide had diabetes in 2021, and this number is expected to rise to 63 million by 2045. Thus, the expected increase in the number of people suffering from diabetes globally may suffer from diabetic ulcers or wounds. This in turn is expected to increase the demand for foam dressing, hence propelling the segment's growth.
Additionally, as per the German Heart Surgery Report 2021 statistics, in 2021, there will be about 161,261 cardiac procedures performed in Germany, out of which 36,714 are heart valve procedures and 19,490 are pacemaker and ICD-related procedures. Thus, the growing number of cardiac surgeries is expected to increase the demand for sacral silicone foam dressing for the prevention of sacral deep tissue injury, hence boosting segment growth.
Furthermore, the growing research and development activity is further boosting the market's growth over the forecast period. For instance, in May 2022, Winner Medical showcased its latest and industry-leading advanced surgical wound care products, such as Transparent Film Dressing, Bordered Silicone Foam Dressing with SAF and Antibiosis Series Products, and its new product, the Carboxymethylcellulose (CMC) Dressing. Also, in March 2021, Smith+Nephew released the findings of a real-world study conducted in Spain that demonstrated how switching to ALLEVYN LIFE foam dressings reduced dressing change frequency and weekly dressing expenditures while enhancing treatment satisfaction for clinicians and patients in a community context.
Therefore, owing to factors such as the rising burden of diabetes and the growing number of cardiac surgeries, as well as increasing company activities, the studied segment is expected to grow over the forecast period.
The growing prevalence of diabetes, along with an increase in spending on healthcare management, is anticipated to increase market growth. For instance, according to the International Diabetes Federation's Diabetes Atlas, Tenth Edition, in 2021, around 32.2 million people in the United States had diabetes, a number projected to grow to 36.3 million by 2045. The rising number of diabetic cases in the nation is expected to increase the number of diabetic ulcer cases and contribute to market growth in the United States.
Additionally, in Canada, numerous wound care associations collaborate to provide world-class treatment for pressure ulcers, specifically hospital-acquired pressure ulcers. For instance, as per the report published by the Canadian Patient Safety Institute in 2021, the net hospitalization cost of hospital-acquired pressure ulcers in the country is approximately CAD 44,000 (USD 32390) to CAD 90,000 (USD 66,253). Pressure ulcers are listed as Required Organizational Practices (ROP) in Accreditation Canada's 2020 handbook.This suggests that there is a growing concern about pressure ulcers across Canada, and wound-related associations are working to address it, which is expected to fuel the growth of the market studied.
Furthermore, the growing number of surgeries in the region is expected to boost segment growth over the forecast period. According to OECD data, approximately 3,154 total knee replacement surgeries will be performed in Mexico in 2022.Thus, growing surgical volume is expected to drive the demand for surgical dressings such as foam or occlusive dressings, thereby boosting the market's growth.
Therefore, owing to the above-mentioned factors, such as the rising burden of diabetes and the increasing number of surgical procedures, as well as growing company and organization activities in the region, the studied market is expected to grow over the forecast period.
This product will be delivered within 2 business days.
COVID-19 had an impact on the surgical dressing market due to the cancellation of elective procedures worldwide, including diagnostics and wound care treatment.Due to the regulatory authorities' strict guidance to prevent any non-emergent surgeries, the volume of surgeries drastically decreased throughout the pandemic. For instance, as per a research article published in the Brazilian Journal of Gynecology and Obstetrics, in July 2020, both the National Health Agency and the National Health Surveillance Agency advised the postponement of elective and non-essential surgeries. This had a considerable impact on the number of surgical procedures, which decreased by 33.4% in the country. However, resumed surgical procedures and wound treatment services have increased demand for the surgical dressing market. For instance, as per an article published in December 2021, a total of 13,108,567 surgical procedures were identified from January 1, 2019, through January 30, 2021, based on 3498 Current Procedural Terminology (CPT) codes. Thus, with the increased number of surgical procedures, the studied market is growing and is expected to reach its full potential in the next two to three years.
Market growth is being helped by things like the rise in lifestyle diseases and the number of surgeries around the world, as well as the rise in the number of ambulatory surgical centers and organ transplants.
The increasing incidences of chronic wounds, ulcers, diabetic ulcers, and burns are the key factor driving the demand for surgical dressings over the forecast period. For instance, according to data published by the NPIAP in August 2021, around 2.5 million people are reported every year with pressure ulcers in the United States. Also, per the report published by the American Burn Association in February 2021, more than 400,000 people receive burn injury treatment every year in the United States.
Additionally, the growing burden of chronic diseases is driving the demand for effective and advanced treatment services involving surgical procedures, which are anticipated to fuel the demand for surgical dressing during surgery, hence propelling the market's growth. For instance, according to the data published by the OECD, in August 2022, about 94.87 thousand surgeries were performed in Portugal, followed by 49.33 thousand in Denmark, 32.84 thousand in Ireland, and 21.5 thousand in Norway in 2021.
Also, the number of knee and hip replacement surgeries has increased globally, and persistent wound drainage is a well-known complication following these procedures, which commonly leads to wound development. This is also expected to increase the demand for surgical dressings, hence bolstering the market's growth. For instance, as per the American Joint Registry 2021 report, more than 2.4 million hip and knee surgeries were reported in the United States in 2021, with an increase of 18.3% in total procedural volume compared to 2020.
Furthermore, the increasing focus of companies on developing effective surgical dressings is also contributing to the growth of the market. For instance, in June 2022, Medline released its Optifoam Gentle EX Foam Dressing. When combined with a pressure injury prevention protocol, the product is intended to help displace pressure. The product has five distinct layers that absorb shear stress, friction, and moisture. Also, in May 2022, the Technical University of Munich (TUM) in Germany developed a new kind of film dressing using mucin molecules that can not only protect wounds like conventional dressings but also add active drugs to accelerate wound healing, expel bacteria, inhibit inflammation, and finally decompose on the skin by itself, which is a new revelation for sensitive skin.
Therefore, owing to the aforementioned factors, the studied market is expected to grow over the forecast period. However, the stringent regulatory policies, lack of reimbursement, and high treatment costs are likely to hinder the growth of the surgical dressing market over the forecast period.
Surgical Dressing Market Trends
Foam Dressing is Expected to Witness Healthy CAGR Over the Forecast Period
The foam dressing segment is expected to witness significant growth in the surgical dressing market over the forecast period. The factors contributing to market growth are increasing burn cases, various ulcers, open wounds, and rising surgical cases across the globe.In addition, diabetes is expected to be a major factor causing wounds. Thus, a rise in the number of people suffering from diabetes is anticipated to drive the market. For instance, as per the 2022 statistics published by the IDF, more than 51 million people in the NAC Region and 537 million people worldwide had diabetes in 2021, and this number is expected to rise to 63 million by 2045. Thus, the expected increase in the number of people suffering from diabetes globally may suffer from diabetic ulcers or wounds. This in turn is expected to increase the demand for foam dressing, hence propelling the segment's growth.
Additionally, as per the German Heart Surgery Report 2021 statistics, in 2021, there will be about 161,261 cardiac procedures performed in Germany, out of which 36,714 are heart valve procedures and 19,490 are pacemaker and ICD-related procedures. Thus, the growing number of cardiac surgeries is expected to increase the demand for sacral silicone foam dressing for the prevention of sacral deep tissue injury, hence boosting segment growth.
Furthermore, the growing research and development activity is further boosting the market's growth over the forecast period. For instance, in May 2022, Winner Medical showcased its latest and industry-leading advanced surgical wound care products, such as Transparent Film Dressing, Bordered Silicone Foam Dressing with SAF and Antibiosis Series Products, and its new product, the Carboxymethylcellulose (CMC) Dressing. Also, in March 2021, Smith+Nephew released the findings of a real-world study conducted in Spain that demonstrated how switching to ALLEVYN LIFE foam dressings reduced dressing change frequency and weekly dressing expenditures while enhancing treatment satisfaction for clinicians and patients in a community context.
Therefore, owing to factors such as the rising burden of diabetes and the growing number of cardiac surgeries, as well as increasing company activities, the studied segment is expected to grow over the forecast period.
North America is Expected to Witness a Significant CAGR Over the Forecast Period
North America is expected to grow over the forecast period owing to factors such as the growing incidence of chronic wounds and ulcers, diabetic foot ulcers, increased surgical procedures, and an increasing demand for faster wound recovery.The growing prevalence of diabetes, along with an increase in spending on healthcare management, is anticipated to increase market growth. For instance, according to the International Diabetes Federation's Diabetes Atlas, Tenth Edition, in 2021, around 32.2 million people in the United States had diabetes, a number projected to grow to 36.3 million by 2045. The rising number of diabetic cases in the nation is expected to increase the number of diabetic ulcer cases and contribute to market growth in the United States.
Additionally, in Canada, numerous wound care associations collaborate to provide world-class treatment for pressure ulcers, specifically hospital-acquired pressure ulcers. For instance, as per the report published by the Canadian Patient Safety Institute in 2021, the net hospitalization cost of hospital-acquired pressure ulcers in the country is approximately CAD 44,000 (USD 32390) to CAD 90,000 (USD 66,253). Pressure ulcers are listed as Required Organizational Practices (ROP) in Accreditation Canada's 2020 handbook.This suggests that there is a growing concern about pressure ulcers across Canada, and wound-related associations are working to address it, which is expected to fuel the growth of the market studied.
Furthermore, the growing number of surgeries in the region is expected to boost segment growth over the forecast period. According to OECD data, approximately 3,154 total knee replacement surgeries will be performed in Mexico in 2022.Thus, growing surgical volume is expected to drive the demand for surgical dressings such as foam or occlusive dressings, thereby boosting the market's growth.
Therefore, owing to the above-mentioned factors, such as the rising burden of diabetes and the increasing number of surgical procedures, as well as growing company and organization activities in the region, the studied market is expected to grow over the forecast period.
Surgical Dressing Market Competitor Analysis
The surgical dressings market is moderately consolidated owing to the presence of a few major market players. The market players are committed to developing innovative healing solutions for customers and patients across the care continuum, generating proven clinical outcomes. The companies are also showing continuous growth and are developing new and differentiated products and services that address the evolving healthcare needs of patients, providers, and consumers. 3M Company, Smith & Nephew, Coloplast, Molnlycke Health Care AB, Cardinal Health Inc., and ConvaTec Group Plc are among the players, as are Johnson & Johnson and Johnson & Johnson.Additional benefits of purchasing the report:
- The market estimate (ME) sheet in Excel format
- 3 months of analyst support
This product will be delivered within 2 business days.
Table of Contents
1 INTRODUCTION
4 MARKET DYNAMICS
5 MARKET SEGMENTATION (Market Size by Value - USD million)
6 COMPETITIVE LANDSCAPE
Companies Mentioned (Partial List)
A selection of companies mentioned in this report includes, but is not limited to:
- 3M Company
- Coloplast
- Molnlycke Health Care AB
- Cardinal Health Inc.
- ConvaTec Group Plc
- Medtronic Plc
- Smith & Nephew Plc
- Medline Industries Inc.
- Advancis Medical
- Johnson and Johnson
- B. Braun SE
